A detailed history of Rothschild Investment LLC transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 15 shares of FLGT stock, worth $275. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15
Previous 10 50.0%
Holding current value
$275
Previous $196,000 66.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$19.6 - $25.06 $98 - $125
5 Added 50.0%
15 $326,000
Q2 2024

Jul 30, 2024

BUY
$19.09 - $22.57 $190 - $225
10 New
10 $196,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $556M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.